PDCD1 and neoplasm: The benefit of microbiota on ICI treatment efficacy is further supported by evidence that faecal microbiota transplantation (FMT) from cancer patients who responded to ICIs improved the anti-tumour effects of PD-1 blockade in germ-free and antibiotic-treated mice [102].